
Bactobio is a biotechnology company focused on unlocking the potential of unculturable microbes through genomics, machine learning, and bioengineering. Their innovative approach aims to discover novel antimicrobials for healthcare and agriculture, addressing critical global challenges such as antimicrobial resistance and environmental sustainability. With a commitment to creating a safer and greener world, Bactobio leverages advanced technologies to develop biodegradable and effective solutions, positioning itself as a leader in the microbial revolution.

Bactobio is a biotechnology company focused on unlocking the potential of unculturable microbes through genomics, machine learning, and bioengineering. Their innovative approach aims to discover novel antimicrobials for healthcare and agriculture, addressing critical global challenges such as antimicrobial resistance and environmental sustainability. With a commitment to creating a safer and greener world, Bactobio leverages advanced technologies to develop biodegradable and effective solutions, positioning itself as a leader in the microbial revolution.
Founded: May 2020
Headquarters: London, United Kingdom
Focus: Using genomics, machine learning and synthetic biology to culture unculturable microbes and discover novel antimicrobials and agricultural bioprotection
Employees (approx.): 54
Total disclosed funding: 12,615,208 USD
Antimicrobial discovery and agricultural bioprotection (culturing unculturable microbes to find new bioactive chemistries).
2020
Biotechnology Research
6,000,000 GBP
Oversubscribed bridge round closed Dec 1, 2022
2,800,000 GBP
Funding round announced Oct 1, 2021 (rebranding to Bactobio)
“Led by Bridford Group for the Dec 2022 bridge/convertible round; company lists angel/advisor investors including Peder Holk Nielsen, Hugh Grant, Jonathan Milner and Claudio Costamagna”
| Company |
|---|
We are looking for a bioinformatician to develop and maintain high throughput computational workflows.
Compan
yBactobio is a young London-based BioTech company (2020) using AI, genomics, and synthetic biology to culture previously unculturable microbes and screen them for antimicrobials. We regularly discover chemically novel antimicrobials that are effective against some of the biggest infectious diseases in agritech and healthcare, and select diseases to target based on the lack of current, effective solutions and the potential market size
.
Our work culture is built around impact, empowerment, and collaboration, and we have managed to attract incredible scientists from world-leading institutions, alongside operational experts. We believe that open and inclusive conversations lead to better solutions. As a result, we have created a unique work environment, where ambitious people enjoy working together to make the world greener and safe
r.
The company is at an very exciting stage, as we are looking forward to our first product commercialisation in H1 2026, after which we intend to undergo a significant series A raise, and use the funds to expand our current team of
50
RoleHelp us discover novel antimicrobials from bacteria by creating bioinformatics pipelines that turn raw microbial sequencing data into trusted, actionable results. You will be responsible for creating robust pipelines, ensuring data is traceable end-to-end across our workflow, and integrating new algorithms to production-ready c
ode.
TeamThe bioinformatics team is part of a tight knit computational group of data scientists and software engineers. We share a codebase and work together to build scaleable infrastructure. We also work closely with wet lab scientists across our core t
**eams.
Key responsibi**
**g data
Skills, Knowledge and Ex**
pertiseYou shoul
detailIt would be great if y
scovery
l advice